|Number of pages||8|
|Journal||International Journal of Epidemiology|
|Early online date||2 Apr 2018|
|Publication status||Published - Jun 2018|
Bibliographical note© The Author(s) 2018
specifically established in the UK in 2004 to address the needs outlined above by producing ‘real-time’, robust generalizable data on haematological malignancies to inform contemporary clinical practice and research: locally, nationally and internationally.28 With core support from Bloodwise [www.bloodwise.org.uk], formerly Leukaemia and Lymphoma Research, HMRN is the result of a unique collaboration between university researchers, National Health Service (NHS) clinicians and patients/carers.
This work was supported by Bloodwise [grant number 15037], and has ethics approval (REC 04/01/1205/69) from Leeds West Research Ethics Committee, R&D approval from each NHS Trust and exemption from Section 251 of the Health & Social Care Act (PIAG 1–05(h)/2007).